Dobutamine-Stress Magnetic Resonance Microimaging in Mice: Acute Changes of Cardiac Geometry and Function in Normal and Failing Murine Hearts

Abstract— The aim of this study was to assess the capability of MRI to characterize systolic and diastolic function in normal and chronically failing mouse hearts in vivo at rest and during inotropic stimulation. Applying an ECG-gated FLASH-cine sequence, MRI at 7 T was performed at rest and after administration of 1.5 &mgr;g/g IP dobutamine. There was a significant increase of heart rate, cardiac output, and ejection fraction and significant decrease of end-diastolic and end-systolic left ventricular (LV) volumes (P <0.01 each) in normal mice during inotropic stimulation. In mice with heart failure due to chronic myocardial infarction (MI), MRI at rest revealed gross LV dilatation. There was a significant decrease of LV ejection fraction in infarcted mice (29%) versus sham mice (58%). Mice with MI showed a significantly reduced maximum LV ejection rate (P <0.001) and LV filling rate (P <0.01) and no increase of LV dynamics during dobutamine action, indicating loss of contractile and relaxation reserve. In 4-month-old transgenic mice with cardiospecific overexpression of the &bgr;1-adrenergic receptor, which at this early stage do not show abnormalities of resting cardiac function, LV filling rate failed to increase after dobutamine stress (transgenic, 0.19±0.03 &mgr;L/ms; wild type, 0.36±0.01 &mgr;L/ms;P <0.01). Thus, MRI unmasked diastolic dysfunction during dobutamine stress. Dobutamine-stress MRI allows noninvasive assessment of systolic and diastolic components of heart failure. This study shows that MRI can demonstrate loss of inotropic and lusitropic response in mice with MI and can unmask diastolic dysfunction as an early sign of cardiac dysfunction in a transgenic mouse model of heart failure.

[1]  M. Pfeffer,et al.  Progressive ventricular remodeling in rat with myocardial infarction. , 1991, The American journal of physiology.

[2]  G Grupp,et al.  Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations. , 1993, The American journal of physiology.

[3]  J. Gardin,et al.  Echocardiographic assessment of left ventricular mass and systolic function in mice. , 1995, Circulation research.

[4]  M. Lohse,et al.  Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Ross,et al.  Transthoracic echocardiography in models of cardiac disease in the mouse. , 1996, Circulation.

[6]  P. Guéret,et al.  Quantitative two dimensional echocardiography during bicycle exercise in normal subjects. , 1981, The American journal of cardiology.

[7]  R G Weiss,et al.  Dynamic magnetic resonance images of murine cardiac function at physiologic heart rates. , 2000, Circulation.

[8]  Stefan Neubauer,et al.  Magnetic resonance microimaging for noninvasive quantification of myocardial function and mass in the mouse , 1998, Magnetic resonance in medicine.

[9]  R. Peshock,et al.  Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α , 1998 .

[10]  R Beyar,et al.  Determination of left ventricular mass by magnetic resonance imaging in hearts deformed by acute infarction. , 1989, Circulation.

[11]  C. G. Blomqvist,et al.  Left Ventricular Performance in Normal Subjects: A Comparison of the Responses to Exercise in the Upright and Supine Positions , 1980, Circulation.

[12]  J. Melin,et al.  Assessment of right and left ventricular volumes during upright exercise in normal men. , 1982, European heart journal.

[13]  M. Pfeffer,et al.  Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management. , 1991, The American journal of cardiology.

[14]  W J Manning,et al.  In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. , 1994, The American journal of physiology.

[15]  Ronald M Peshock,et al.  Magnetic Resonance Imaging and Invasive Evaluation of Development of Heart Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α , 1999 .

[16]  S. Pawlowski,et al.  Rescue of cardiac α-actin-deficient mice by enteric smooth muscle γ-actin , 1997 .

[17]  R. Peshock,et al.  Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. , 1998, Circulation.

[18]  A. Koretsky,et al.  Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .

[19]  G. Dorn,et al.  Transgenic Gαq overexpression induces cardiac contractile failure in mice , 1997 .

[20]  K. Chien,et al.  Ventricular Expression of a MLC-2v-ras Fusion Gene Induces Cardiac Hypertrophy and Selective Diastolic Dysfunction in Transgenic Mice (*) , 1995, The Journal of Biological Chemistry.

[21]  R. Lefkowitz,et al.  Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. , 1994, Science.

[22]  M. Daemen,et al.  Chronic myocardial infarction in the mouse: cardiac structural and functional changes. , 1999, Cardiovascular research.

[23]  J. Gardin,et al.  Gated magnetic resonance imaging of normal and hypertrophied murine hearts. , 1997, The American journal of physiology.

[24]  C. Higgins,et al.  Quantification of the left ventricular volumes and function with cine MR imaging: comparison of geometric models with three-dimensional data. , 1993, Radiology.

[25]  R. Lefkowitz,et al.  Enhanced Myocardial Function inTransgenic Mice Overexpressing theP2-Adrenergic Receptor , 1994 .

[26]  Donald S. Williams,et al.  Cardiac MRI of the normal and hypertrophied mouse heart , 1998, Magnetic resonance in medicine.

[27]  A Haase,et al.  Developmental changes of cardiac function and mass assessed with MRI in neonatal, juvenile, and adult mice. , 2000, American journal of physiology. Heart and circulatory physiology.

[28]  R. Walsh,et al.  In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. , 1995, Circulation research.